Fil LTD Astrazeneca PLC Transaction History

Fil LTD

$116 Billion
Q3 2025

A detailed history of Fil LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Fil LTD holds 727 shares of AZN stock, worth $64,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares

727

Previous 518 40.35%

Holding current value

$64,993

Previous $36,000 52.78%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$68.72 - $82.11 $14,362 - $17,160	209 Added 40.35%	727 $55,000
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $1,232 - $1,425	19 Added 3.81%	518 $36,000
Q1 2025 May 12, 2025	BUY	$65.37 - $77.96 $653 - $779	10 Added 2.04%	499 $36,000
Q4 2024 Feb 13, 2025	SELL	$63.2 - $79.58 $758 - $954	-12 Reduced 2.4%	489 $32,000
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $6,363 - $7,272	83 Added 19.86%	501 $39,000

Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $9,353 - $11,316	140 Added 50.36%	418 $32,000
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $1,891 - $2,156	31 Added 12.55%	278 $18,000
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $3,527 - $3,948	57 Added 30.0%	247 $16,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $518 - $573	8 Added 4.4%	190 $12,000
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $4,963 - $5,382	71 Added 63.96%	182 $13,000
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $5,683 - $6,443	90 Added 428.57%	111 $7,000
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $596 - $774	11 Added 110.0%	21 $1,000
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $530 - $1,357	10 New	10 $1,000

Others Institutions Holding AZN

# of Institutions

1,497

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account